EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease

Masashi Akiyama iD

The Journal of Dermatology · 2025-03 · 52 (3) · 400-407

DOI: 10.1111/1346-8138.17585 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, online erschienen am 19.12.2024. Verfasst von Masashi Akiyama. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Japan Society for the Promotion of Science (JSPS), the Ministry of Health, Labor and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Generalized pustular psoriasis (GPP) is a severe autoinflammatory keratinization disease (AiKD) characterized by acute flares of widespread sterile pustules and high fever. GPP is potentially life‐threatening. Recently clarified genetic predisposing factors for GPP suggest that the excessive activation of innate immune pathways in the skin, including of interleukin (IL)‐1 and IL‐36 signaling, plays a significant role in the GPP pathogenesis. IL36RN , CARD14 , AP1S3 , MPO , SERPINA3 , BTN3A3 , and MEFV have been identified as GPP‐related genes. The pathogenesis of GPP provoked by variants in these seven genes is tightly associated with the excessive activation of innate immune pathways and the resulting autoinflammation in the skin. Various biologics, including inhibitors for the tumor necrosis factor, IL‐17, and IL‐23 pathways, are used as treatments for GPP. The new understanding of the genetic background of GPP, mentioned above, indicates that the genetic predisposing factors are predominantly related to the excessive activation of innate immunity and autoinflammation. In this context, inhibitors of inflammatory signaling, including of the IL‐1 and IL‐36 pathways, have been used in clinical practice and investigated as potential future therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHumansGenetic Predisposition to DiseaseInterleukin-1Immunity, InnateCARD Signaling Adaptor ProteinsSignal TransductionGuanylate CyclaseBiological ProductsSkinInterleukinsMembrane Proteins

Stichwörter der Autor:innen

MEFVCARD14IL‐36autoinflammationpyrin

Substanzen

Interleukin-1CARD Signaling Adaptor ProteinsCARD14 protein, humanGuanylate CyclaseBiological ProductsIL36RN protein, humanInterleukinsMembrane Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID-Profile: Masashi Akiyama

Förderung

  • Wellcome Trust
  • Japan Society for the Promotion of Science (JSPS)
  • the Ministry of Health, Labor and Welfare of Japan

Zitieren

APA

Akiyama, M. (2025). Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease. The Journal of Dermatology, 52(3), 400-407. https://doi.org/10.1111/1346-8138.17585

Vancouver

Akiyama M. Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease. The Journal of Dermatology. 2025;52(3):400-407. doi:10.1111/1346-8138.17585

BibTeX
@article{Akiyama2025,
  author = {Akiyama, Masashi},
  title = {Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease},
  journal = {The Journal of Dermatology},
  year = {2025},
  volume = {52},
  number = {3},
  pages = {400--407},
  doi = {10.1111/1346-8138.17585}
}
Kostenlos starten →